{"DataElement":{"publicId":"2529200","version":"1","preferredName":"Loss Gene Expression Immunohistochemistry Staining Method Finding Delta Benign Invasive Positive Finding java.lang.Integer","preferredDefinition":"A gradual decline in amount or activity.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._A change in or difference between; usually represented by the 4th letter of the greek alphabet.:Mild in nature, not dangerous to health.  It is used to describe neoplastic processes which are not locally invasive and do not metastasize.:Marked by a tendency to spread, especially into healthy surrounding tissue.:An observation confirming the presence of a disease, condition, or microorganism._Generic value domain for a primitive java dataype that is an Integer (32-bit two's complement).","longName":"2528905v1.0:2178537v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2528905","version":"1","preferredName":"Loss Gene Expression Immunohistochemistry Staining Method Finding Delta Benign Invasive Positive Finding","preferredDefinition":"A gradual decline in amount or activity.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._A change in or difference between; usually represented by the 4th letter of the greek alphabet.:Mild in nature, not dangerous to health.  It is used to describe neoplastic processes which are not locally invasive and do not metastasize.:Marked by a tendency to spread, especially into healthy surrounding tissue.:An observation confirming the presence of a disease, condition, or microorganism.","longName":"2528742v1.0:2528658v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2528742","version":"1","preferredName":"Loss Gene Expression Immunohistochemistry Staining Method Finding","preferredDefinition":"A gradual decline in amount or activity.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom).","longName":"C25559:C16608:C23020:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss","conceptCode":"C25559","definition":"A gradual decline in amount or activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"20415841-395F-0263-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2528658","version":"1","preferredName":"Delta Benign Invasive Positive Finding","preferredDefinition":"A change in or difference between; usually represented by the 4th letter of the greek alphabet.:Mild in nature, not dangerous to health.  It is used to describe neoplastic processes which are not locally invasive and do not metastasize.:Marked by a tendency to spread, especially into healthy surrounding tissue.:An observation confirming the presence of a disease, condition, or microorganism.","longName":"C54126:C14172:C14159:C38758","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Delta","conceptCode":"C54126","definition":"A change in or difference between; usually represented by the 4th letter of the greek alphabet.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Benign","conceptCode":"C14172","definition":"For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"20414863-4F38-6DA5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20416C70-3A1F-135F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2178537","version":"1","preferredName":"java.lang.Integer","preferredDefinition":"Generic value domain for a primitive java dataype that is an Integer (32-bit two's complement).","longName":"java.lang.Integer","context":"caCORE","contextVersion":"1","type":"Non-enumerated","dataType":"java.lang.Integer","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2178532","version":"1","preferredName":"Bioinformatics","preferredDefinition":".","longName":"BIOINFORMATICS","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"CD81DD3C-8FFA-28BA-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-02","endDate":"2020-10-14","createdBy":"SBREXT","dateCreated":"2003-12-02","modifiedBy":"TAYLORT","dateModified":"2020-10-14","changeDescription":"10.14.20 TL changed WFS from DRAFT NEW to RETIRED ARCHIVED and added an End Date in preparation of OneData.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233101","version":"1","preferredName":"Number","preferredDefinition":"Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F920A342-1134-2A6A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD831153-DAB1-28B6-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-02","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-02","modifiedBy":"CURTIST","dateModified":"2007-12-05","changeDescription":"03/30/2006 - Updated definition and datatype (previously Number.)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2528519","version":"2","longName":"caIntegrator","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812323","version":"1","longName":"gov.nih.nci.caintegrator.domain.finding.protein.ihc","context":"NCIP"}]},{"publicId":"2707890","version":"2.1","longName":"caIntegrator 2.1","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000564","version":"1","longName":"gov.nih.nci.caintegrator.domain.finding.protein.ihc","context":"NCIP"}]}],"AlternateNames":[{"name":"gov.nih.nci.caintegrator.domain.finding.protein.ihc.LossOfExpressionIHCFinding.invasiveBenignDiff","type":"UML Qualified Attr","context":"NCIP"},{"name":"LossOfExpressionIHCFinding:invasiveBenignDiff","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Data Element Loss Gene Expression Immunohistochemistry Staining Method Finding Delta Benign Invasive Positive Finding java.lang.Integer does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Loss Gene Expression Immunohistochemistry Staining Method Finding Delta Benign Invasive Positive Finding java.lang.Integer does not have Preferred Question Text","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20408E54-6735-30C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"CURTIST","dateModified":"2008-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}